Patients taking prescription opioids and gabapentin concomitantly have a 49% greater risk for opioid-related death than those treated with opioids only, according to a new Canadian study.
Researchers led by Tara Gomes, PhD, MHSc, the principal investigator of the Ontario Drug Policy Research Network (ODPRN), used administrative databases to compare opioid users who died of an opioid-related cause (n=1,256) with controls (n=4,619) matched according to